IL6 and non-small cell lung carcinoma: They also observed a decreased number of myeloid cells and a substantially decreased expression of genes induced by type I interferon, IFNγ and IL-6 in the tumors of infected patients with NSCLC undergoing anti-PD1 treatment [31].